As of January 22, 2025, 2seventy bio (TSVT) has a market cap of $0.13 billion USD. According to our data, 2seventy bio is ranked No.7492 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.13 B |
-14.29%
|
Dec 31, 2024 | $0.15 B |
-31.15%
|
Dec 29, 2023 | $0.22 B |
-54.43%
|
Dec 30, 2022 | $0.48 B |
-63.44%
|
Dec 31, 2021 | $1.32 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
bluebird bio
BLUE
|
$76.22 M |
0.000 M
|
USA
|
CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
USA
|
Intellia Therapeutics
NTLA
|
$1.12 B |
0.000 M
|
USA
|
Beam Therapeutics
BEAM
|
$2.19 B |
0.000 M
|
USA
|
Sangamo Therapeutics
SGMO
|
$0.24 B |
-0.000 M
|
USA
|
Fate Therapeutics
FATE
|
$0.15 B |
0.000 M
|
USA
|
Allogene Therapeutics
ALLO
|
$0.40 B |
0.000 M
|
USA
|
Cellectis
CLLS
|
$0.16 B |
4.659 M
|
France
|
Precision BioSciences
DTIL
|
$38.13 M |
0.000 M
|
USA
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Novartis
NVS
|
$196.27 B |
-0.007 M
|
Switzerland
|
Bristol-Myers Squibb
BMY
|
$115.79 B |
-0.003 M
|
USA
|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Market Cap | = | TSVT Stock Price | * | TSVT Shares Outstanding |
= | $2.52 | * | 51.59 M | |
= | $0.13 B |